These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37896163)

  • 1. Efficacy of Apremilast Gels in Mouse Model of Imiquimod-Induced Psoriasis Skin Inflammation.
    Silva-Abreu M; Sosa L; Espinoza LC; Fábrega MJ; Rodríguez-Lagunas MJ; Mallandrich M; Calpena AC; Garduño-Ramírez ML; Rincón M
    Pharmaceutics; 2023 Sep; 15(10):. PubMed ID: 37896163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocrystal-based gel of apremilast ameliorates imiquimod-induced psoriasis by suppressing inflammatory responses.
    Parmar PK; Sharma N; Wasil Kabeer S; Rohit A; Bansal AK
    Int J Pharm; 2022 Jun; 622():121873. PubMed ID: 35640806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation characterization of lecithin organogel as topical drug delivery system for psoriasis: In-vitro permeation and preclinical evaluation.
    Bule P; Kadkanje P; Kshirsagar R; Puppala ER; Naidu VGM; Chella N
    Drug Dev Res; 2024 May; 85(3):e22191. PubMed ID: 38685610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD44 Assists the Topical Anti-Psoriatic Efficacy of Curcumin-Loaded Hyaluronan-Modified Ethosomes: A New Strategy for Clustering Drug in Inflammatory Skin.
    Zhang Y; Xia Q; Li Y; He Z; Li Z; Guo T; Wu Z; Feng N
    Theranostics; 2019; 9(1):48-64. PubMed ID: 30662553
    [No Abstract]   [Full Text] [Related]  

  • 5. Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis.
    Schafer PH; Parton A; Gandhi AK; Capone L; Adams M; Wu L; Bartlett JB; Loveland MA; Gilhar A; Cheung YF; Baillie GS; Houslay MD; Man HW; Muller GW; Stirling DI
    Br J Pharmacol; 2010 Feb; 159(4):842-55. PubMed ID: 20050849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
    Ma L; Xue H; Qi R; Wang Y; Yuan L
    J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms Underlying the Clinical Effects of Apremilast for Psoriasis.
    Pincelli C; Schafer PH; French LE; Augustin M; Krueger JG
    J Drugs Dermatol; 2018 Aug; 17(8):835-840. PubMed ID: 30124722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gentiopicroside-Loaded Chitosan Nanoparticles Inhibit TNF-α-Induced Proliferation and Inflammatory Response in HaCaT Keratinocytes and Ameliorate Imiquimod-Induced Dermatitis Lesions in Mice.
    Zhao K; Pu S; Sun L; Zhou D
    Int J Nanomedicine; 2023; 18():3781-3800. PubMed ID: 37457802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphodiesterase 4 in inflammatory diseases: Effects of apremilast in psoriatic blood and in dermal myofibroblasts through the PDE4/CD271 complex.
    Schafer PH; Truzzi F; Parton A; Wu L; Kosek J; Zhang LH; Horan G; Saltari A; Quadri M; Lotti R; Marconi A; Pincelli C
    Cell Signal; 2016 Jul; 28(7):753-63. PubMed ID: 26806620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous delivery of α-melanocyte-stimulating hormone for the treatment of imiquimod-induced psoriasis.
    Shah PP; Desai PR; Boakye CH; Patlolla R; Kikwai LC; Babu RJ; Singh M
    J Drug Target; 2016; 24(6):537-47. PubMed ID: 26582563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice.
    Choi MR; Kim HD; Cho S; Jeon SH; Kim DH; Wee J; Yang YD
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betulin-NLC-hydrogel for the Treatment of Psoriasis-like Skin Inflammation: Optimization, Characterisation, and In vitro and In vivo Evaluation.
    Prakash D; Chaudhary A; Chaudhary A
    Curr Drug Deliv; 2024 Oct; ():. PubMed ID: 39360545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apremilast downregulates interleukin-17 production and induces splenic regulatory B cells and regulatory T cells in imiquimod-induced psoriasiform dermatitis.
    Uchida H; Kamata M; Shimizu T; Egawa S; Ito M; Takeshima R; Mizukawa I; Watanabe A; Tada Y
    J Dermatol Sci; 2021 Oct; 104(1):55-62. PubMed ID: 34548208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Extracellular Vesicles from the Commensal Staphylococcus Epidermidis ATCC12228 Strain Regulate Skin Inflammation in the Imiquimod-Induced Psoriasis Murine Model.
    Gómez-Chávez F; Cedillo-Peláez C; Zapi-Colín LA; Gutiérrez-González G; Martínez-Torres I; Peralta H; Chavez-Galan L; Avila-Calderón ED; Contreras-Rodríguez A; Bartolo-Aguilar Y; Rodríguez-Martínez S; Cancino-Diaz ME; Cancino-Diaz JC
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.
    Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC
    J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apremilast increases IL-10-producing regulatory B cells and decreases proinflammatory T cells and innate cells in psoriatic arthritis and psoriasis.
    Mavropoulos A; Zafiriou E; Simopoulou T; Brotis AG; Liaskos C; Roussaki-Schulze A; Katsiari CG; Bogdanos DP; Sakkas LI
    Rheumatology (Oxford); 2019 Dec; 58(12):2240-2250. PubMed ID: 31209492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production.
    Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ
    Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice.
    Sun J; Zhao Y; Hu J
    PLoS One; 2013; 8(6):e67078. PubMed ID: 23825622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18β-Glycyrrhetinic acid induces human HaCaT keratinocytes apoptosis through ROS-mediated PI3K-Akt signaling pathway and ameliorates IMQ-induced psoriasis-like skin lesions in mice.
    Gao J; Guo J; Nong Y; Mo W; Fang H; Mi J; Qi Q; Yang M
    BMC Pharmacol Toxicol; 2020 Jun; 21(1):41. PubMed ID: 32493482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model.
    Liu C; Liu H; Lu C; Deng J; Yan Y; Chen H; Wang Y; Liang CL; Wei J; Han L; Dai Z
    Clin Exp Immunol; 2019 Dec; 198(3):403-415. PubMed ID: 31407330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.